Vascular nitric oxide production during the development of two experimental models of portal hypertension

Journal of Hepatology

Volumn 30, Issue 5, 1999, Pages 896-903

  Gadano, Adrián C ^a   Sogni, Philippe ^a   Heller, Jörg ^a   Moreau, Richard ^a   Bories, Phuong Nhi ^b   Lebrec, Didier ^a  

^a BEAUJON HOSPITAL   (France)

^b Hopital Albert Chenevier   (France)

Author keywords

Aortic rings; Cirrhosis; Nitric oxide synthase; Vascular reactivity

Indexed keywords

ISOENZYME; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME SYNTHESIS; LIVER CIRRHOSIS; MALE; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; VASCULAR RING; VASODILATATION;

EID: 0033066322     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80145-7     Document Type: Article

References (45)

1. Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology. 20:1994;1359-1363.
2. Bomzon A, Blendis LM. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis. Hepatology. 20:1994;1343-1350.
3. Sogni P, Moreau R, Gadano A, Lebrec D. The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. J Hepatol. 23:1995;218-224.
4. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem. 269:1994;13725-13728.
5. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1989;664-666.
6. Lowenstein CJ, Dinerman J, Snyder S. Nitric oxide: a physiological messenger. Ann Intern Med. 120:1994;227-237.
7. Bredt DS, Hwang PM, Glatt CG, Lowenstein C, Reed RR, Snayder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 351:1991;714-718.
8. Nunokawa Y, Ishida N, Tanaka S. Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Comm. 191:1993;89-94.
9. Forstermann U, Pollock JS, Schmidt HHHW, Heller M, Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proc Natl Acad Sci USA. 88:1991;1788-1792.
10. Busse R, Mulsch A. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett. 265:1990;133-136.
11. Miller V.M, Aarhus LL, Vanhoutte PM. Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am J Physiol. 251:1986;H520-H527.
12. Busse R, Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 265:1990;87-90.
13. Schini V B, Junquero DC, Scott-Burden T, Vanhoutte PM. Interleukin-1β induces the production of an L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochem Biophys Res Commun. 176:1991;114-121.
14. Schini VB, Vanhoutte PM. Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta. J Pharmacol Exp Ther. 261:1992;553-559.
15. Griffiths MJ, Messent M, MacAllister R, Evans T. Aminoguanidine inhibits inducible nitric oxide synthase. Br J Pharmacol. 110:1993;963-968.
16. Cahill PA, Redmond EM, Hodges R, Zhang S, Sitzmann JV. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. J Hepatol. 25:1996;370-378.
17. Martin P, Ding L, Niedeberger M, Weigert A, Tsai P, St John J, et al. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol. 270:1996;F494-F499.
18. Fernandez M, Garcia Pagan JC, Casadevall AM, Bernadich C, Piera C, Whittle BJ, et al. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology. 108:1995;1487-1495.
19. Heinemann A, Stauber RE. The role of inducible nitric oxide synthase in vascular hyporeactivity of endotoxin-treated and portal hypertensive rats. Eur J Pharmacol. 78:1995;87-90.
20. Lopez-Talavera JC, Merrill WW, Groszmann RJ. Tumor necrosis factor α: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology. 108:1995;761-777.
21. Niederberger M, Martin PY, Ginès P, Morris K, Tsai P, Xu DL, et al. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology. 109:1995;1624-1630.
22. Gadano A, Sogni P, Yang S, Cailmail S, Moreau R, Nepveux P, et al. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats. J Hepatol. 26:1997;678-686.
23. Morales-Ruiz M, Jiménez W, Perez-Sala D, Ros J, Leivas A, Lamas S, et al. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology. 24:1996;1481-1486.
24. Atucha N, Shah V, García Cardeña G, Sessa W, Groszmann RJ. Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis. Gastroenterology. 111:1996;1627-1632.
25. Sogni P, Smith APL, Gadano A, Lebrec D, Higenbottam TW. Induction of nitric oxide synthase II does not account for excess vascular nitric oxide production. J Hepatol. 26:1997;1120-1127.
26. Lebrec D. Animal models of portal hypertension. Okuda K, Benhamou JP, . Portal Hypertension: Clinical and Physiological Aspects. 1991;101-113 Springer-Verlag, Tokyo.
27. w-Nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol. 176:1990;219-223.
28. Bories PN, Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem. 41:1995;904-907.
29. Bredt DS, Snyder SH. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 87:1990;682-685.
30. Cahill PA, Foster C, Redmond EM, Gingalewski C, Wu Y, Sitzmann JV. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology. 22:1995;598-606.
31. Martin PY, Ohara M, Gines P, Xu DL, St John J, Niederberger M, et al. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest. 101:1998;235-242.
32. Guarner C, Soriano G, Tomas A, Bulbena O, Novella M, Balanzo J, et al. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology. 15:1993;1139-1143.
33. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet. 337:1991;776-778.
34. Brinkmann A, Wolf CF, Berger D, Kneitinger E, Neumeister B, Buchler M, et al. Perioperatory endotoxemia and bacterial translocation during major abdominal surgery: evidence for the protective effect of endogenous prostacyclin? Crit Care Med. 24:1996;1293-1301.
35. Berger D, Schmidt UM, Ott S, Seidelmann M, Martin R, Beger H. Incidence and pathophysiological relevance of postoperative endotoxemia. Immunol Med Microbiol. 11:1995;285-290.
36. Rockey DC, Chung JJ. Regulation of inducible nitric oxide synthase during liver injury. [abstract] Hepatology. 22:1995;249A.
37. Colombato L, Albillos A, Groszmann RJ. Temporal relationship of peripheral vasodilatation, plasma volume expansion and the hyperdynamic circulatory state in portal hypertensive rats. Hepatology. 15:1992;323-328.
38. Lee FY, Colombato L, Albillos A, Groszmann R. N-Nitro-L-arginine administration corrects peripheral vasodilatation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology. 17:1993;84-90.
39. García-Pagán JC, Fernández M, Bernadich C, Pizcueta P, Piqué J, Bosch J, et al. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat. Am J Physiol. 267:1994;G984-G990.
40. Castro A, Jiménez W, Claria J, Ros J, Martinez JM, Bosch M, et al. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology. 18:1993;367-372.
41. Sieber CC, Groszmann RJ. Nitric oxide mediates in vitro hyporeactivity to vasopresssors in mesenteric vessels of portal hypertensive rats. Gastroenterology. 103:1992;235-239.
42. Sogni P, Sabry S, Chabot F, Moreau R, Gadano A, Lebrec D, et al. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats. J Hepatol. 24:1996;487-490.
43. Weinheimer G, Osswald H. Inhibition of endothelium-dependent smooth muscle relaxation by calmodulin antagonists. Nauyun-Schmiedeberg's Arch Pharmacol. 332:1986;391-397.
44. Niederberger M, Gines P, Martin PY, Tsai P, Morris K, McMurtry I, et al. Comparisions of vascular nitric oxide production on systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology. 24:1996;947-951.
45. Hadoke PW, Hayes PC. In vivo evidence for vascular hyporesponsiveness in clinical and experimental cirrhosis. Pharmacol Ther. 75:1997;51-68.